home All News open_in_new Full Article

ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation

Manufacturing of validated dengue epitope underway; proprietary immunization studies in rabbit model to assess monoclonal antibody (mAb) responses. AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discovery today announced the next milestone in its universal dengue vaccine program. Building on its […]


today 2 w. ago attach_file Sport

attach_file Society
attach_file Other
attach_file Other
attach_file Events
attach_file Events
attach_file Society
attach_file Culture
attach_file Events
attach_file Society
attach_file Economics
attach_file Society
attach_file Other
attach_file Other
attach_file Events
attach_file Events
attach_file Other
attach_file Economics
attach_file Politics
attach_file Events
attach_file Society


ID: 3612805739
Add Watch Country

arrow_drop_down